The Lyme Disease Association Inc. announces that the new HHS Tick-Borne Disease Working Group (TBDWG) has selected co-chairs from the TBDWG for its 6 newly formed sub-committees. LDA President Pat Smith will be co-chair the Disease Vectors, Surveillance and Prevention (includes epidemiology of tick-borne diseases) Subcommittee. The other co-chair is Dr. Ben Beard, Acting Deputy […]
Govt. Departments & Policies
The departments and agencies of the federal government often play a role in Lyme disease. They may issue policies, guidelines, advisories, or other information which may be useful to Lyme patients, doctors, or the general public. LDA may link to or list some of those government publications which it feels may be important. Complete agency or department information on Lyme disease may be found on each individual agency/department website.
Candy Brassard, Senior Biologist, U.S. Environmental Protection Agency Office of Pesticide Programs; C. Ben Beard, PhD, Director, Bacterial Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control & Prevention at a Meeting at EPA on Lyme in Virginia in 2006.
The new HHS Tick-Borne Disease Working Group (TBDWG) is seeking nominations from federal employees and members of the public who are interested in being considered for appointments to subcommittees being established to provide information for the TBDWG. Nominations will be accepted until midnight on January 7, 2018. The new HHS Tick-Borne Disease Working Group (TBDWG) […]
The Lyme Disease Association (LDA) reports that the U.S. Department of Health and Human Services announced on November 22, 2017, the appointment of 14 members, 7 federal and 7 non-federal, to the new HHS Tick-Borne Disease Working Group. Lyme Disease Association President Pat Smith was one of 7 non-federal appointees to the Working Group, which was established through […]
The Lyme Disease Association announced that early today, July 14, the US Department of Health & Human Services (HHS) released its intent to establish the Tick-Borne Disease (TBD) Working Group called for in Section 2062 of the 21st Century Cures Act. The working group will assist HHS in its efforts to conduct and support epidemiological, […]
The Lyme Disease Association (LDA) is alerting you to the Department of Defense Congressionally Directed Medical Research Program (CDMRP) Program Announcement for FY 2017 CDMRP research grant submissions. The Lyme Disease Association is providing the link to the CDMRP Tick-Borne Disease Research Program. All questions should be addressed to the CDMRP. The FY17 TBDRP Program […]
The Department of Defense Congressionally Directed Medical Research Program (CDMRP) is alerting Lyme & other tick-borne diseases researchers to the potential for anticipated FY17 monies that might become available through the program so that researchers can plan for possible grant submissions. The Lyme Disease Association is providing the link to the CDMRP program. All questions […]
The Congressionally Directed Medical Research Program (CDMRP) has announced funding opportunities under the auspices of the Tick-Borne Diseases Programmatic Panel. $5 million has been appropriated for tick-borne diseases research through the Department of Defense budget for the 2016 (FY16) CDMRP program. Research specifically involving the following areas is being sought: Pathogenesis: Host-pathogen interactions Human immune […]
Signons from Lyme Group Leaders on FDA Test TakeoverThe Lyme Disease Association, Inc. (LDA) has formulated a response to FDA to be included in its comment period on its testing Guidance which will affect specialty lab Lyme tests. Therefore, groups who want to support the position taken by the LDA may join in on the […]
FDA is moving forward in the process of finalizing its new Laboratory Developed Test (LDT) Guidance proposal. The proposal would move LDTs from under the jurisdiction of Clinical Laboratory Improvement Amendment (CLIA) regulated by Medicare & Medicaid Services to under the jurisdiction of the Food & Drug Administration (FDA). The FDA now regulates non-LDT lab tests under […]
Time Sensitive Survey: The Food & Drug Administration (FDA) is poised to develop new regulations which may affect access to existing tests for Lyme and other tick-borne diseases. Please click on the link to complete a survey being done by LymeDisease.org, an affiliate of the Lyme Disease Association. The information is needed for upcoming meetings […]